Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
50.5M
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
22M
-
Shares change
-
+2.99M
-
Total reported value, excl. options
-
$384M
-
Value change
-
+$52.3M
-
Number of buys
-
47
-
Number of sells
-
-16
-
Price
-
$17.46
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) as of Q4 2020
75 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Mirum Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (MIRM) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22M shares
of 50.5M outstanding shares and own 43.61% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), FRAZIER MANAGEMENT LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.45M shares), Novo Holdings A/S (2.45M shares), Rock Springs Capital Management LP (1.5M shares), BAKER BROS. ADVISORS LP (647K shares), VANGUARD GROUP INC (628K shares), BlackRock Inc. (555K shares), DRIEHAUS CAPITAL MANAGEMENT LLC (544K shares), and Sio Capital Management, LLC (495K shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.